Treatment options Metastatic melanoma :
{"Image DocumentName": "Treatment options Metastatic melanoma :", "Image ImageDescription": "1st FDA approved treatment is high dose IL-2 (Proleukin) which is considered as 1st line treatment. Other options include: Yervoy (Anti-CTLA-4) Vemufenib (BRAF inhibitor) Clinical trial. Adjuvant therapy is appropriate for melanoma that has been surgically removed: Standard of care is close follow-up. Other options include: Interferon. Clinical trial.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}